Bayer has said a new UK court ruling could limit off-label use of Roche's Avastin in ophthalmology by imposing stricter safety and consent measures. The UK’s Court of Appeal has upheld a lower ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback